PCRX
Pacira BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PCRX vs peer average
65/100
PCRX vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 5 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
OMER is the first available peer comparator.
Similar market-cap biotech peer from the packet, but Omeros is a loose comp rather than a direct operating peer; useful mainly for small-cap biotech risk appetite, not for commercial pain-franchise benchmarking.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PCRX
Pacira Biosciences
OMER
Omeros
Grade
B
D
Momentum
43
10
Value
69
41
Sentiment
48
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs OMER
PCRX / OMER
Grade Position
In line
PCRX vs. peer average (B vs. C)
65/100
Momentum
43
PCRXValue
69
PCRXSentiment
48
OMERRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PCRX
OMER is the first peer returned for this comparison set.